Pfizer v. Mylan
A federal court in Pittsburgh upheld Pfizer Inc.'s U.S. patent covering the active ingredient in Norvasc, which is used for treating hypertension. Mylan Laboratories tried to cash in on the billion dollar drug by making a generic version, which was said to infringe on Pfizer's patent. The decision, which Mylan... Continue reading
















And the winners are...



